Browse > Article

Effect of Photodynamic Therapy in Lung Cancer  

Yoon, Sung Ho (Department of Internal Medicine, Chosun University, College of Medicine)
Han, Kyung Taek (Department of Internal Medicine, Chosun University, College of Medicine)
Kim, Gyung Nam (Department of Internal Medicine, Chosun University, College of Medicine)
Lee, Seung Il (Department of Internal Medicine, Chosun University, College of Medicine)
Publication Information
Tuberculosis and Respiratory Diseases / v.57, no.4, 2004 , pp. 358-363 More about this Journal
Abstract
Background : Photodynamic therapy (PDT) involves the use of photosensitizing agents for treatment of malignant disease. PDT is approved by the U.S. Food and Drug Administration for the endobronchial microinvasive nonsmall cell lung cancer and for palliation in patients with obstructing tumors. We report our experience and results of PDT in lung cancer. Method : Ten patients with lung cancer who were diagnosed in Chosun university hospital by histologic confirm through bronchoscopy were included between August 2002 and May 2003. The photosensitizer (Photogem$^{(R)}$, Lomonosov institute of Fine Chemical, Russia/dose 2.0 mg/kg body weight) was injected 48 hours prior to the PDT session. For PDT with the photosensitizer (Photogem$^{(R)}$), Diode LASER system (Biolitec Inc., Germany, wavelength; 633nm) were used. PDTs were done at 48-72 hours after photogem injection. Follow up bronchoscopy and chest X-ray or thorax computerized tomography were done for evaluate PDT response. Results : 9 of 10 patients with endobronchial obstruction showed partial remission with bronchus opening after PDT. Direct reaction of the tumor to PDT was similar in despite of its localization. It was as follows; edema, hyperemia, in-situ bleeding, fibrin film occurrence. Any other complications such as sunburns of skin, inflammation within the PDT zone were not occurred by the end of the fourth week. Conclusion : In the advanced endobronchial disease, PDT has been shown to be useful in treating endobronchial tumors that are causing clinically significant dyspnea or are likely to progress and lead to further clinical complications, such as postobstructive pneumonia.
Keywords
Lung cancer; Photodynamic therapy (PDT); Palliation;
Citations & Related Records

Times Cited By SCOPUS : 3
연도 인용수 순위
1 Kelly JF, Snell ME, Berenhaum MC. Photodynamic destruction of human bladder carcinoma. Br J Cancer 1975;31:237-44
2 Diaz-Jimenez JP, Martinez-Ballarin JE, Llunell A, Farrero E, Rodriguez A, Castro MJ. Efficacy and safety of photodynamic therapy versus Nd-YAG laserresection in NSCLC with airway obstruction. Eur Respir J 1999;14:800-5.
3 Lam S, Crofton C, Cory P. Combined photodynamic therapy (PDT) using Photofrin and radiotherapy (XRT) versus radiotherapy alone in patients withinoperable distribution non-small cell bronchogenic cancer. Proc Intl Soc Optical Engin 1991(SPIE) 20-8
4 Spiro SG, Porter JC. Porter, Lung Cancer-where are we today?: Current advances in staging and nonsurgical treatment. Am J Respir Crit Care Med 2002;166:1166-96
5 Edell ES, Cortese DA. Photodynamic therapy in the management of early superficial squamous cell carcinoma as an alternative to surgical resection. Chest 1992;102:1319-22
6 Gregorie HG. Jr, Horger EO, Ward JL. Hematoporphyrin derivative fluorescence I Malignant neoplasms. Ann Surg 1968;167:820-8
7 Moghissi K, Dixon K, Parsons RJ. A controlled trial of Nd-YAG vs Photodynamic therapy for advanced malignant bronchial obstruction. Lasers Med Sci 1993;8:269-73
8 McCaughan JS Jr. Photodynamic therapy of endobronchial and esophageal tumors: an overview. J Clin Laser Med Surg 1996;14:223-33
9 Marcus SL. Clinical photodynamic therapy: the continuing evolution. In: Henderson BW, Dougherty TJ, editors. Photodynamic therapy. New York: MarcelDekker Inc., 1992.;219-68
10 Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, et al. Photodynamic therapy. J Natl Cancer Inst 1998;90:889-905
11 Cortese DA, Edell ES, Kinsey JH. Photodynamic therapy for early stage squamous cell carcinoma of the lung. Mayo Clin Proc 1997;72:595-602
12 Dougherty TJ, Kaufman JE, Goldfarb A. Weishaupt KR, Bouleo, Mzfflewar A Photoradiationtherapy for the treatment of malignant tumors. Cancer Res 1978;38:2628-35
13 Kim YS, Park JS, Jee YK, Lee KY. Photodynamic therapy induced cell death using ALA and 632nm diode Laser in A549 lung cancer cells. Tuberculosis and Respiratory Disease. 2004;56:178-86
14 Okunaka T, Kato H, Tsutsui H, Ishizumi T, Ichinose S, Kuroiwa Y. Photodynamic therapy for peripheral lung cancer. Lung Cancer 2004;43:77-82
15 Lipson RL, Baldes EJ, Gray MS. Hematoporphyrin derivative for detection and management of cancer. Cancer. 1967;20:2255-7
16 Kato H, Okunaka T, Shimatani H. Photodynamic therapy for early stage bronchogenic carcinoma. J Clin Laser Meg Surg 1996;14:235-8
17 Moghissi K, Dixon K, Stringer M, Freeman T, Thorpe A, Brown S. The place of bronchoscopic photodynamic therapy in advanced unresectable lung cancer: experience of 100 cases. Eur J Cardiothorac Surg 1999;15:1-6
18 John DM. Chapter 88. Neoplasms of the lung. In:Braunwald E, Hauser SL, Fauci AS, Longo DL, Kasper DL, Jameson JL, editors. Harrison’s principles of internal medicine. 15th Ed. New York: McGraw-Hill, Inc; 2001. p 567